NCT00774995View on ClinicalTrials.gov

Immune Response of Healthy Subjects Who Received Neonatal Vaccination Course With Engerix™-B Vaccine.

PHASE4CompletedINTERVENTIONAL

Enrollment

49

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions

Hepatitis B

Interventions

BIOLOGICAL

EngerixTM-B

Intramuscular injection, one dose.

Trial Locations (1)

10330

GSK Investigational Site, Bangkok

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT00774995 - Immune Response of Healthy Subjects Who Received Neonatal Vaccination Course With Engerix™-B Vaccine. | Biotech Hunter | Biotech Hunter